A detailed history of Concord Wealth Partners transactions in Haleon PLC stock. As of the latest transaction made, Concord Wealth Partners holds 194 shares of HLN stock, worth $1,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares
194
Holding current value
$1,881
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$8.32 - $10.7 $1,614 - $2,075
194 New
194 $2,000
Q3 2023

Apr 30, 2024

BUY
$7.85 - $8.94 $2,716 - $3,093
346 New
346 $2,000
Q4 2022

Jan 27, 2023

BUY
$5.96 - $8.06 $2,062 - $2,788
346 New
346 $2,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.